These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28163728)

  • 21. Oesophageal involvement during attacks in pemphigus vulgaris patients.
    Calka O; Akdeniz N; Tuncer I; Metin A; Cesur RS
    Clin Exp Dermatol; 2006 Jul; 31(4):515-9. PubMed ID: 16716152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Clinicopathological Study of Pemphigus in Eastern India with Special Reference to Direct Immunofluorescence.
    Chowdhury J; Datta PK; Chowdhury SN; Das NK
    Indian J Dermatol; 2016; 61(3):288-94. PubMed ID: 27293249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical aspects and immunopathology in 48 patients with pemphigus].
    Hahn K; Kippes W; Amagai M; Rzany B; Bröcker EB; Zillikens D
    Hautarzt; 2000 Sep; 51(9):670-7. PubMed ID: 11057394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemphigus vulgaris and complications of systemic corticosteroid therapy: a case report.
    Sakallioglu EE; Acikgoz G; Keles G; Senturk N; Karagoz F
    J Oral Sci; 2003 Sep; 45(3):165-9. PubMed ID: 14650582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies.
    Mimouni D; Foedinger D; Kouba DJ; Orlow SJ; Rappersberger K; Sciubba JJ; Nikolskaia OV; Cohen BA; Anhalt GJ; Nousari CH
    J Am Acad Dermatol; 2004 Jul; 51(1):62-7. PubMed ID: 15243525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus.
    Yoshida K; Takae Y; Saito H; Oka H; Tanikawa A; Amagai M; Nishikawa T
    J Am Acad Dermatol; 2005 May; 52(5):839-45. PubMed ID: 15858475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging treatment options for the management of pemphigus vulgaris.
    Kridin K
    Ther Clin Risk Manag; 2018; 14():757-778. PubMed ID: 29740210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful management of pediatric oral pemphigus vulgaris with topical corticosteroid monotherapy.
    Le M; Ghazawi FM; Miedzybrodzki B; Chauvin PJ; Jafarian F
    Pediatr Dermatol; 2019 Sep; 36(5):730-731. PubMed ID: 31177575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral mucosal disease: pemphigus.
    Scully C; Mignogna M
    Br J Oral Maxillofac Surg; 2008 Jun; 46(4):272-7. PubMed ID: 17870218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
    Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
    Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Childhood pemphigus vulgaris is a challenging diagnosis.
    Lins GT; Barbosa NLS; de Abreu EMV; da Costa KVT; Meneses KCB; Silva RN; Ferreira SMS
    Autops Case Rep; 2021; 11():e2021267. PubMed ID: 34307224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles.
    Veldman C; Stauber A; Wassmuth R; Uter W; Schuler G; Hertl M
    J Immunol; 2003 Jan; 170(1):635-42. PubMed ID: 12496453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between the efficacy of intralesional rituximab versus intralesional triamcinolone in the treatment refractory Pemphigus Vulgaris lesions: A randomized clinical trial.
    Iraji F; Danesh F; Faghihi G; Siadat A; Mokhtari F; Talakoob M; Hafezi H
    Int Immunopharmacol; 2019 Aug; 73():94-97. PubMed ID: 31082727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.
    Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M
    Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation-induced pemphigus vulgaris of the breast.
    Vigna-Taglianti R; Russi EG; Denaro N; Numico G; Brizio R
    Cancer Radiother; 2011 Jul; 15(4):334-7. PubMed ID: 21511511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
    Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies.
    Ruocco V; Ruocco E; Lo Schiavo A; Brunetti G; Guerrera LP; Wolf R
    Clin Dermatol; 2013; 31(4):374-381. PubMed ID: 23806154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pemphigus vulgaris in distant relatives of two families: association with major histocompatibility complex class II genes.
    Bhol K; Yunis J; Ahmed AR
    Clin Exp Dermatol; 1996 Mar; 21(2):100-3. PubMed ID: 8759194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cutaneous pemphigus vulgaris. A case report].
    Bello C; Mondaca-Cornejo L; Navarrete-Dechent C; González S
    Rev Med Chil; 2013 Apr; 141(4):525-30. PubMed ID: 23900375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles.
    Ding X; Aoki V; Mascaro JM; Lopez-Swiderski A; Diaz LA; Fairley JA
    J Invest Dermatol; 1997 Oct; 109(4):592-6. PubMed ID: 9326396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.